Antoni Ribas, M.D., serves as a Professor of medicine, surgery, and molecular and medical pharmacology at the University of California Los Angeles (UCLA). He was trained at the University of Barcelona, Spain, with postdoctoral research and clinical fellowship at UCLA. He is the Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC), the Chair of the Melanoma Committee at SWOG, Permanent Committee Member of the National Cancer Institute (NCI) grant review panels and an elected member of the American Society of Clinical Investigation (ASCI). Dr. Ribas is a physician-scientist conducting laboratory and clinical research focused in malignant melanoma, including adoptive cell transfer with T-cell receptor (TCR) engineered lymphocytes, anti-CTLA4 antibodies, targeted therapies for melanoma oncogenes, and nanoparticle-siRNA.
Biography Updated on 24 April 2012